[5-min read] Ketamine company receives one of nine FDA Commissioner's National Priority Vouchers.
[5-min read] Q&A with Joe Moore, CEO & Cofounder
[3-min read] Psychedelic facilitators explain when to journey with support and when to go solo.
[5-min read] atai receives FDA's sixth breakthrough therapy designation for a psychedelic drug.
[5-min read] Q&A with Mikki Vogt, Clinical Facilitator & Founder
[3-min read] Facilitators weigh in on whether to proceed with a psychedelic session after experiencing trauma.
[5-min read] Crossover trial examines the key differences between MDMA and MDA.
[5-min read] Q&A with Greg Fonzo, Psychologist & Researcher
[3-min read] Psychedelic facilitators explain how to connect with spirit guides.
[6-min read] New research reveals how psilocybin breaks the pain-depression cycle.
[5-min read] Q&A with Ismail "Izzy" Ali, Co-Executive Director
[3-min read] Facilitators share how to make sense of psychedelic visuals.
